Aluminum and its potential contribution to Alzheimer's disease (AD)

Frontiers in Aging Neuroscience

Volumn 6, Issue APR, 2014, Pages

  Bhattacharjee, Surjyadipta ^a   Zhao, Yuhai ^a,b   Hill, James M ^a,b   Percy, Maire E ^c,d   Lukiw, Walter J ^a,b  

^a LOUISIANA STATE UNIVERSITY HEALTH SCIENCES CENTER   (United States)

^b LOUISIANA STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF TORONTO   (Canada)

^d Neurogenetics Laboratory   (Canada)

Author keywords

Aluminum; Alzheimer's disease; Desferrioxamine; Feralex G; Genetic variability; Micro RNA (mirna); Tg2576

Indexed keywords

ALUMINUM; ALUMINUM POTASSIUM SULFATE; ALUMINUM SULFATE; DEFEROXAMINE; FERALEX G; UNCLASSIFIED DRUG;

ALZHEIMER DISEASE; GENE EXPRESSION; HUMAN; LIPID PEROXIDATION; NEUROPATHOLOGY; NONHUMAN; NOTE;

EID: 84901298455     PISSN: None     EISSN: 16634365     Source Type: Journal    
DOI: 10.3389/fnagi.2014.00062     Document Type: Note

References (34)

1. Alexandrov, P. N., Zhao, Y., Jones, B. M., Bhattacharjee, S., and Lukiw, W. J. (2013). Expression of the phagocytosis-essential protein TREM2 is down-regulated by an aluminum-induced miRNA-34a in a microglial cell line. J. Inorg. Biochem. 128, 267-269. doi: 10.1016/j.jinorgbio.2013.05.010
2. Alexandrov, P. N., Zhao, Y., Pogue, A. I., Tarr, M. A., Kruck, T. P., Percy, M. E., et al. (2005). Synergistic effects of iron and aluminum on stress-related gene expression in primary human neural cells. J. Alzheimers Dis. 8, 117-127; discussion 209-215
3. Bharathi, V., Vasudevaraju, P., Govindaraju, M., Palanisamy, A. P., Sambamurti, K., and Rao, K. S. (2008). Molecular toxicity of aluminium in relation to neurodegeneration. Indian J. Med. Res. 128, 545-556
4. Bhattacharjee, S., Zhao, Y., Hill, J. M., Culicchia, F., Kruck, T. P., Percy, M. E., et al. (2013). Selective accumulation of aluminum in cerebral arteries in Alzheimer's disease. J. Inorg. Biochem. 126, 35-37. doi: 10.1016/j.jinorgbio.2013.05.007
5. Bondy, S. C. (2013). Prolonged exposure to low levels of aluminum leads to changes associated with brain aging and neurodegeneration. Toxicology 315, 1-7. doi: 10.1016/j.tox.2013.10.008
6. Bryant, P. L., Lukiw, W. J., Gan, Z., Hall, R. W., and Butler, L. G. (2004). High-field 19.6T 27Al solid-state MAS NMR of in vitro aluminated brain tissue. J. Magn. Reson. 170, 257-262. doi: 10.1016/j.jmr.2003.12.013
7. Colangelo, V., Schurr, J., Ball, M. J., Pelaez, R. P., Bazan, N. G., and Lukiw, W. J. (2002). Gene expression profiling of 12633 genes in Alzheimer hippocampal CA1: transcription and neurotrophic factor down-regulation and up-regulation of apoptotic and pro-inflammatory signaling. J. Neurosci. Res. 70, 462-473. doi: 10.1002/jnr.10351
8. Crapper McLachlan, D. R., Dalton, A. J., Kruck, T. P., Bell, M. Y., Smith, W. L., Kalow, W., et al. (1991). Intramuscular desferrioxamine in patients with Alzheimer's disease. Lancet 337, 1304-1308. doi: 10.1016/0140-6736(91)92978-B
9. De Sole, P., Rossi, C., Chiarpotto, M., Ciasca, G., Bocca, B., Alimonti, A., et al. (2013). Possible relationship between Al/ferritin complex and Alzheimer's disease. Clin. Biochem. 46, 89-93. doi: 10.1016/j.clinbiochem.2012.10.023
10. Exley, C. (2005). The aluminium-amyloid cascade hypothesis and Alzheimer's disease. Subcell. Biochem. 38, 225-234. doi: 10.1007/0-387-23226-5_11
11. Flaten, T. P. (2001). Aluminium as a risk factor in Alzheimer's disease. Brain Res. Bull. 55, 187-196. doi: 10.1016/S0361-9230(01)00459-2
12. Frisardi, V., Solfrizzi, V., Capurso, C., Kehoe, P. G., Imbimbo, B. P., Santamato, A., et al. (2010). Aluminum in the diet and Alzheimer's disease: from current epidemiology to possible disease-modifying treatment. J. Alzheimers Dis. 20, 17-30. doi: 10.3233/JAD-2009-1340
13. Ginsberg, S. D., Alldred, M. J., and Che, S. (2012). Gene expression levels assessed by CA1 pyramidal neuron and regional hippocampal dissections in Alzheimer's disease. Neurobiol. Dis. 45, 99-107. doi: 10.1016/j.nbd.2011.07.013
14. Guo, H., Ingolia, N. T., Weissman, J. S., and Bartel, D. P. (2010). Mammalian microRNAs predominantly act to decrease target mRNA levels. Nature 466, 835-840. doi: 10.1038/nature09267
15. Hill, J. M., Zhao, Y., Bhattacharjee, S., and Lukiw, W. J. (2014). miRNAs and viroids utilize common strategies in genetic signal transfer. Front. Mol. Neurosci. 7:10. doi: 10.3389/fnmol.2014.00010
16. Kruck, T. P., Cui, J. G., Percy, M. E., and Lukiw, W. J. (2004). Molecular shuttle chelation: the use of ascorbate, desferrioxamine and Feralex-G in combination to remove nuclear bound aluminum. Cell. Mol. Neurobiol. 24, 443-459. doi: 10.1023/B:CEMN.0000022773.70722.b2
17. Kruck, T. P., Percy, M. E., and Lukiw, W. J. (2008). Metal sulfate-mediated induction of pathogenic genes and repression by phenyl butyl nitrone and Feralex-G. Neuroreport 19, 245-249. doi: 10.1097/WNR.0b013e3282f4cb7e
18. Lukiw, W. J. (2010). Evidence supporting a biological role for aluminum in brain chromatin compaction and epigenetics. J. Inorg. Biochem. 104, 1010-1012. doi: 10.1016/j.jinorgbio.2010.05.007
19. Lukiw, W. J., Kruck, T. P., and McLachlan, D. R. (1987). Alterations in human linker histone-DNA binding in the presence of aluminum salts in vitro and in Alzheimer's disease. Neurotoxicology 8, 291-301
20. Lukiw, W. J., Kruck, T. P., and McLachlan, D. R. C. (1989). Aluminium and the nucleus of nerve cells. Lancet 1, 781. doi: 10.1016/S0140-6736(89)92596-8
21. Lukiw, W. J., and Pogue, A. I. (2007). Induction of specific micro RNA (miRNA) species by ROS-generating metal sulfates in primary human brain cells. J. Inorg. Biochem. 101, 1265-1269. doi: 10.1016/j.jinorgbio.2007.06.004
22. Maciotta, S., Meregalli, M., and Torrente, Y. (2013). The involvement of microRNAs in neurodegenerative diseases. Front. Cell Neurosci. 7:265. doi: 10.3389/fncel.2013.00265
23. Percy, M. E., Kruck, T. P., Pogue, A. I., and Lukiw, W. J. (2011). Towards the prevention of potential aluminum toxic effects and an effective treatment for Alzheimer's disease. J. Inorg. Biochem. 105, 1505-1512. doi: 10.1016/j.jinorgbio.2011.08.001
24. Pogue, A. I., Jones, B. M., Bhattacharjee, S., Percy, M. E., Zhao, Y., and Lukiw, W. J. (2012). Metal-sulfate induced generation of ROS in human brain cells: detection using an isomeric mixture of 5- and 6-carboxy-2',7'-dichlorofluorescein diacetate (carboxy-DCFDA) as a cell permeant tracer. Int. J. Mol. Sci. 13, 9615-9626. doi: 10.3390/ijms13089615
25. Pogue, A. I., Li, Y. Y., Cui, J. G., Zhao, Y., Kruck, T. P., Percy, M. E., et al. (2009). Characterization of an NF-kB-regulated, miRNA-146a-mediated down-regulation of CFH in metal- stressed brain cells. J. Inorg. Biochem. 103, 1591-1595. doi: 10.1016/j.jinorgbio.2009.05.012
26. Praticò, D., Uryu, K., Sung, S., Tang, S., Trojanowski, J. Q., and Lee, V. M. (2002). Aluminum modulates brain amyloidosis through oxidative stress in APP transgenic mice. FASEB J. 16, 1138-1140. doi: 10.1096/fj.02-0012fje
27. Rodella, L. F., Ricci, F., Borsani, E., Stacchiotti, A., Foglio, E., Favero, G., et al. (2008). Aluminium exposure induces Alzheimer's disease-like histopathological alterations in mouse brain. Histol. Histopathol. 23, 433-439
28. Shaw, C. A., and Tomljenovic, L. (2013). Aluminum in the central nervous system (CNS): toxicity in humans and animals, vaccine adjuvants, and autoimmunity. Immunol. Res. 56, 304-316. doi: 10.1007/s12026-013-8403-1
29. Walker, P. R., LeBlanc, J., and Sikorska, M. (1989). Effects of aluminum and other cations on the structure of brain and liver chromatin. Biochemistry 28, 3911-3915. doi: 10.1021/bi00435a043
30. Walton, J. R. (2013). Aluminum involvement in the progression of Alzheimer's disease. J. Alzheimers Dis. 35, 7-43. doi: 10.3233/JAD-121909. Review Erratum in: J. Alzheimers Dis. (2013), 35:875
31. Walton, J. R., and Wang, M. X. (2009). APP expression, distribution and accumulation are altered by aluminum in a rodent model for Alzheimer's disease. J. Inorg. Biochem. 103, 1548-1554. doi: 10.1016/j.jinorgbio.2009.07.027
32. Yumoto, S., Kakimi, S., Ohsaki, A., and Ishikawa, A. (2009). Demonstration of aluminum in amyloid fibers in the cores of senile plaques in the brains of patients with Alzheimer's disease. J. Inorg. Biochem. 103, 1579-1584. doi: 10.1016/j.jinorgbio.2009.07.023
33. Zhang, Q. L., Jia, L., Jiao, X., Guo, W. L., Ji, J. W., Yang, H. L., et al. (2012). APP/PS1 transgenic mice treated with aluminum: an update of Alzheimer's disease model. Int. J. Immunopathol. Pharmacol. 25, 49-58
34. Zhao, Y., Bhattacharjee, S., Jones, B. M., Hill, J., Dua, P., and Lukiw, W. J. (2013). Regulation of neurotropic signaling by the inducible, NF-kB-sensitive miRNA-125b in Alzheimer's disease (AD) and in primary human neuronal-glial (HNG) cells. Mol Neurobiol. doi: 10.1007/s12035-013-8595-3. [Epub ahead of print]